Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 05 Apr 2023
A new study suggests that once adults reach age 65, the cutoff age for Alzheimer's disease onset, the extent of their genetic risk may outweigh age as a predictor of whether they will experience the fatal brain disorder.
Read Full NewsThe tool, based on histology only, may help identify patients most likely to benefit from triplet therapy.
Experts tout common characteristics of local physician practices that are beneficial to those with advanced disease.
1.
EMA Recommends Generic in Advanced/Metastatic Breast Cancer
2.
Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer
3.
Why breast cancer survivors don't take their medicine, and what can be done about it.
4.
As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.
5.
Advanced breast cancer patients living longer thanks to improvements in treatment and care
1.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
2.
Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy
3.
Living Better With Advanced Cancer Through Supportive Care
4.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
5.
Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
Navigating the Complexities of Ph Negative ALL - Part XII
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge